UNIVERSITY OF ROCHESTER

UNIVERSITY OF ROCHESTER logo
🇺🇸United States
Ownership
Private
Established
1850-01-01
Employees
10K
Market Cap
-
Website
http://www.rochester.edu

Acupressure and Relaxation for Nausea Control

Phase 1
Completed
Conditions
Interventions
First Posted Date
2005-10-21
Last Posted Date
2015-06-18
Lead Sponsor
University of Rochester
Target Recruit Count
83
Registration Number
NCT00243269
Locations
🇺🇸

University of Rochester James P. Wilmot Cancer Center, Rochester, New York, United States

Nesiritide and Vo2 Max in Heart Failure Patients

Phase 2
Completed
Conditions
Interventions
First Posted Date
2005-10-17
Last Posted Date
2013-06-19
Lead Sponsor
University of Rochester
Target Recruit Count
20
Registration Number
NCT00240084
Locations
🇺🇸

University of Rochester Medical Center, Rochester, New York, United States

Effect of Benadryl Sedation During ERCP or EUS

First Posted Date
2005-10-17
Last Posted Date
2015-09-18
Lead Sponsor
University of Rochester
Registration Number
NCT00240123

In Home Hospital Care Program

Not Applicable
Completed
Conditions
First Posted Date
2005-10-07
Last Posted Date
2007-08-16
Lead Sponsor
University of Rochester
Target Recruit Count
200
Registration Number
NCT00234780
Locations
🇺🇸

University of Rochester, Rochester, New York, United States

Health-e-Access Telemedicine in Primary Pediatric Care

Not Applicable
Completed
Conditions
Interventions
First Posted Date
2005-10-07
Last Posted Date
2015-10-22
Lead Sponsor
University of Rochester
Target Recruit Count
2000
Registration Number
NCT00234806
Locations
🇺🇸

University of Rochester, Rochester, New York, United States

Maternal Problem-Solving in Childhood Cancer

Phase 3
Completed
Conditions
First Posted Date
2005-10-07
Last Posted Date
2015-06-15
Lead Sponsor
University of Rochester
Target Recruit Count
433
Registration Number
NCT00234793
Locations
🇺🇸

Oregon Health Sciences University, Portland, Oregon, United States

🇺🇸

UT/MD Anderson Cancer Center, Houston, Texas, United States

🇺🇸

Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, United States

and more 1 locations

Effects of SomatoKine (Iplex)Recombinant Human Insulin-like Growth Factor-1/Recombinant Human Insulin-like Growth Factor-binding Protein-3 (rhIGF-I/rhIGFBP-3) in Myotonic Dystrophy Type 1 (DM1)

Phase 1
Completed
Conditions
Interventions
First Posted Date
2005-10-05
Last Posted Date
2012-06-25
Lead Sponsor
University of Rochester
Target Recruit Count
17
Registration Number
NCT00233519
Locations
🇺🇸

University of Rochester Medical Center, Rochester, New York, United States

Pilot Study to Assess the Effectiveness of Tonsil and Adenoidectomy (T+A) in Overweight Children and Adolescents

First Posted Date
2005-09-22
Last Posted Date
2009-02-13
Lead Sponsor
University of Rochester
Target Recruit Count
250
Registration Number
NCT00222963
Locations
🇺🇸

University of Rochester, Rochester, New York, United States

Safety and Tolerability Study of Phenylbutyrate in Huntington's Disease (PHEND-HD)

Phase 2
Completed
Conditions
First Posted Date
2005-09-21
Last Posted Date
2012-08-15
Lead Sponsor
University of Rochester
Target Recruit Count
60
Registration Number
NCT00212316
Locations
🇺🇸

Johns Hopkins University, Baltimore, Maryland, United States

🇺🇸

Massachusetts General Hospital, Boston, Massachusetts, United States

🇺🇸

University of California-San Diego, San Diego, California, United States

and more 5 locations

Aspirin Prophylaxis in Sickle Cell Disease

Phase 1
Completed
Conditions
Interventions
First Posted Date
2005-09-15
Last Posted Date
2017-11-06
Lead Sponsor
University of Rochester
Target Recruit Count
11
Registration Number
NCT00178464
© Copyright 2024. All Rights Reserved by MedPath